Cargando…
Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses
BACKGROUND. There are limited data on the clinical benefits of adding surgical resection in patients with focally progressive gastrointestinal stromal tumor (GIST). This study aims to compare the clinical outcomes of resection plus imatinib dose escalation or maintenance (S group) with imatinib dose...
Autores principales: | Cho, Hyungwoo, Ryu, Min‐Hee, Lee, Yongjune, Park, Young Soo, Kim, Ki‐Hun, Kim, Jwa Hoon, Park, Yangsoon, Lee, Sun Mi, Kim, Chan Wook, Kim, Beom Soo, Yoo, Moon‐Won, Kang, Yoon‐Koo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975948/ https://www.ncbi.nlm.nih.gov/pubmed/31315961 http://dx.doi.org/10.1634/theoncologist.2019-0009 |
Ejemplares similares
-
The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors
por: Keung, Emily Z., et al.
Publicado: (2020) -
Defining Tumor Rupture in Gastrointestinal Stromal Tumor
por: Nishida, Toshirou, et al.
Publicado: (2019) -
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor
por: Venkataraman, Vinayak, et al.
Publicado: (2023) -
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
por: Hølmebakk, Toto, et al.
Publicado: (2021) -
Percutaneous Cementoplasty for the Pelvis in Bone Metastasis: 12-Year Experience
por: Park, Jong Woong, et al.
Publicado: (2021)